NORCROSS, Ga.– Immucor, a provider of blood transfusion technology, and its chief executive officer have reached a settlement with the Securities and Exchange Commission following an investigation of its Italian subsidiary.
The company did not receive a financial penalty and is not required to take any further action, Immucor said in a statement.
CEO Gioacchino De Chirico has agreed to pay a $30,000 civil penalty without admitting or denying any wrongdoing.
The case revolved around payments allegedly made to an Italian physician, according to the Atlanta Business Chronicle.
In a separate matter, Immucor also has received court approval of a class action settlement from a federal court. Immucor’s insurance company will pay $2.5 million to settle claims in the suit.
